[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].

Adult Aged Anemia, Hemolytic/chemically induced Aromatic Amino Acid Decarboxylase Inhibitors Blood Cell Count Carboxy-Lyases/antagonists & inhibitors Chorea Constipation/chemically induced Desipramine/therapeutic use Dihydroxyphenylalanine/administration & dosage,adverse effects Edema/chemically induced Female Humans Hypotension/chemically induced Lymphocytosis/chemically induced Male Middle Aged Movement Disorders/chemically induced,drug therapy Nausea/chemically induced Parkinson Disease/drug therapy Reticulocytes/physiopathology Vomiting/chemically induced

Aromatic Amino Acid Decarboxylase Inhibitors Dihydroxyphenylalanine Carboxy-Lyases Desipramine